
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Ashland Global Holdings Inc (ASH)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/06/2025: ASH (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $68.11
1 Year Target Price $68.11
6 | Strong Buy |
1 | Buy |
4 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -15.68% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.32B USD | Price to earnings Ratio - | 1Y Target Price 68.11 |
Price to earnings Ratio - | 1Y Target Price 68.11 | ||
Volume (30-day avg) 11 | Beta 0.51 | 52 Weeks Range 44.84 - 96.06 | Updated Date 06/30/2025 |
52 Weeks Range 44.84 - 96.06 | Updated Date 06/30/2025 | ||
Dividends yield (FY) 3.27% | Basic EPS (TTM) -1.88 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.8% | Operating Margin (TTM) 6.68% |
Management Effectiveness
Return on Assets (TTM) 2.28% | Return on Equity (TTM) -3.02% |
Valuation
Trailing PE - | Forward PE 10.02 | Enterprise Value 3635712924 | Price to Sales(TTM) 1.19 |
Enterprise Value 3635712924 | Price to Sales(TTM) 1.19 | ||
Enterprise Value to Revenue 1.87 | Enterprise Value to EBITDA 54.26 | Shares Outstanding 45694500 | Shares Floating 45123810 |
Shares Outstanding 45694500 | Shares Floating 45123810 | ||
Percent Insiders 1.07 | Percent Institutions 95.99 |
Analyst Ratings
Rating 4 | Target Price 68.11 | Buy 1 | Strong Buy 6 |
Buy 1 | Strong Buy 6 | ||
Hold 4 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Ashland Global Holdings Inc

Company Overview
History and Background
Ashland Global Holdings Inc. was founded in 1924 as Ashland Refining Company. It has evolved from a petroleum refiner to a global specialty chemical company, divesting its refining business over time.
Core Business Areas
- Life Sciences: Provides solutions for pharmaceutical, nutraceutical, and personal care markets, focusing on excipients, controlled release technologies, and performance ingredients.
- Specialty Additives: Develops and markets additives for coatings, adhesives, construction, and energy markets, enhancing product performance and sustainability.
- Intermediates: Produces BDO (Butanediol) and associated products which are raw materials for manufacturing polymers, solvents and fine chemicals.
Leadership and Structure
The company is led by Guillermo Novo (Chairman and CEO). It has a typical corporate structure with functional departments like finance, marketing, and operations.
Top Products and Market Share
Key Offerings
- Benecelu2122: Cellulose ethers used as excipients in pharmaceutical formulations. Ashland has a significant market share in cellulose ethers for pharmaceutical applications. Competitors include Dow, Shin-Etsu Chemical.
- Aquaflowu2122: Rheology modifiers for waterborne coatings. Ashland is a leading provider of rheology modifiers for the coatings industry. Competitors include BASF, Elementis Specialties.
- Butanediol (BDO): Chemical intermediate for polymers and solvents with various end-use applications. Competitors are LyondellBasell, Genomatica.
Market Dynamics
Industry Overview
The specialty chemicals industry is characterized by innovation, customization, and a focus on performance. Demand is driven by various end-use markets like pharmaceuticals, coatings, and construction.
Positioning
Ashland is positioned as a specialty chemical company focused on high-value, differentiated products and solutions. Its competitive advantage lies in its technical expertise, customer relationships, and product portfolio.
Total Addressable Market (TAM)
The global specialty chemicals market is estimated to be worth hundreds of billions of dollars. Ashland targets specific segments within this TAM, positioning itself to capture growth in selected niche markets.
Upturn SWOT Analysis
Strengths
- Strong product portfolio
- Technical expertise and innovation
- Customer relationships
- Global presence
- Focus on sustainability
Weaknesses
- Dependence on raw material prices
- Exposure to cyclical industries
- Integration risks from acquisitions
- Debt levels can be a concern
Opportunities
- Growing demand for specialty chemicals in emerging markets
- Increasing focus on sustainability and green chemistry
- Potential for new product development
- Acquisitions to expand product portfolio and geographic reach
Threats
- Economic downturns
- Increased competition
- Fluctuations in raw material prices
- Changes in regulations
- Disruptive technologies
Competitors and Market Share
Key Competitors
- DD
- IFF
- EMN
Competitive Landscape
Ashland's competitive advantage lies in its specialized product offerings and customer-centric approach. Its disadvantages may include its smaller scale compared to larger competitors.
Major Acquisitions
Pharmachem
- Year: 2017
- Acquisition Price (USD millions): 660
- Strategic Rationale: Expanded Ashland's presence in the nutraceuticals market.
Growth Trajectory and Initiatives
Historical Growth: Historical growth information is not available without real-time updates.
Future Projections: Future projections are not available without real-time updates.
Recent Initiatives: Recent initiatives are not available without real-time updates.
Summary
Ashland is a specialty chemical company with a focus on high-value products. Its strengths lie in its product portfolio, innovation, and customer relationships. Ashland needs to monitor raw material prices and economic conditions, but overall is stable. The company should continue focusing on expanding in the pharmaceutical sector through excipients.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Financial news sources
- Ashland Global Holdings Inc Investor Relations
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market share and financial data are estimates and may not be precise. All investment decisions should be made based on your own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ashland Global Holdings Inc
Exchange NYSE | Headquaters Wilmington, DE, United States | ||
IPO Launch date 1983-04-06 | Chairman & CEO Mr. Guillermo Novo | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 3200 | Website https://www.ashland.com |
Full time employees 3200 | Website https://www.ashland.com |
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.